Hypertension and its treatment in the NINDS rt-PA Stroke Trial.
暂无分享,去创建一个
J. Grotta | J. Broderick | J. Marler | B. Tilley | R. Kothari | T. Brott | Mei Lu | M. Lu | C. Lewandowski | E. Haley | S. Fagan | M. Frankel | T. Kwiatkowski | M. Lu | E. C. Haley
[1] M. Hennerici,et al. Optimizing Intensive Care in Stroke: A European Perspective , 1997 .
[2] T. N. t-P. S. S. Group,et al. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. , 1997, Stroke.
[3] N L Geller,et al. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. , 1996, Stroke.
[4] G. Hankey,et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. , 1996, JAMA.
[5] M. Hommel,et al. Thrombolytic therapy with streptokinase in acute ischemic stroke. , 1996, The New England journal of medicine.
[6] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[7] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[8] L. Munari,et al. RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE , 1995 .
[9] M. Kaste,et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.
[10] P. Toutouzas,et al. Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease , 1995, The Lancet.
[11] J. Grotta,et al. Guidelines for the Management of Patients With Acute Ischemic Stroke A Statement for Healthcare Professionals , 2005 .
[12] J. Broderick,et al. Factors Related to Intracranial Hematoma Formation in Patients Receiving Tissue‐Type Plasminogen Activator forAcute Ischemic Stroke , 1994, Stroke.
[13] J. Broderick,et al. Blood pressure during the first minutes of focal cerebral ischemia. , 1993, Annals of emergency medicine.
[14] J. Grotta,et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. , 1993, Archives of neurology.
[15] J. Marler,et al. Factors Related to Intracranial Hematoma Formation in Patients Receiving t-PA for Acute Ischemic Stroke , 1993 .
[16] J. Marler,et al. Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset , 1992, Stroke.
[17] J. Broderick,et al. Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.
[18] C. Fisher. Medical Therapy of Acute Stroke , 1989 .
[19] T. Brott,et al. Intensive care for acute stroke in the community hospital setting. The first 24 hours. , 1989, Stroke.
[20] M. Cowan,et al. American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.